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Abstract
Background: Dietary or therapeutic interventions to counteract the loss of PTEN expression could contribute to
the prevention of prostate carcinogenesis or reduce the rate of cancer progression. In this study, we investigate
the interaction between sulforaphane, a dietary isothiocyanate derived from broccoli, PTEN expression and gene
expression in pre malignant prostate tissue.
Results: We initially describe heterogeneity in expression of PTEN in non-malignant prostate tissue of men
deemed to be at risk of prostate cancer. We subsequently use the mouse prostate-specific PTEN deletion model, to
show that sulforaphane suppresses transcriptional changes induced by PTEN deletion and induces additional
changes in gene expression associated with cell cycle arrest and apoptosis in PTEN null tissue, but has no effect on
transcription in wild type tissue. Comparative analyses of changes in gene expression in mouse and human
prostate tissue indicate that similar changes can be induced in humans with a broccoli-rich diet. Global analyses of
exon expression demonstrated that sulforaphane interacts with PTEN deletion to modulate alternative gene
splicing, illustrated through a more detailed analysis of DMBT1 splicing.
Conclusion: To our knowledge, this is the first report of how diet may perturb changes in transcription induced by
PTEN deletion, and the effects of diet on global patterns of alternative gene splicing. The study exemplifies the
complex interaction between diet, genotype and gene expression, and the multiple modes of action of small
bioactive dietary components.
Background
Prostate cancer, one of the more common neoplasms in
the western world, arises through the progressive devel-
opment of one or more pre neoplastic lesions into adeno-
carcinoma, and subsequently to metastatic disease.
Recent advances have identified key genetic alterations
that can initiate prostate carcinogenesis, and enhance the
probability of cancer progression. Foremost amongst
these is the deletion or inactivation of the PTEN tumour
suppressor gene, an antagonist of the phosphatidylinosi-
tol-3-kinase (PI3K/AKT) signaling pathway that
promotes cell survival and proliferation. PTEN deletion
in an epithelial stem cell can be an early initiating event
leading to prostatic intraepithelial neoplasia (PIN), and
subsequently to cancer [1,2]. Thus, heterogeneity in
expression of PTEN in the aging prostate tissue may lead
to the development of multifocal pre invasive lesions.
Therapeutic and dietary approaches to target prostate
cells with PTEN deletion and hyperactivated PI3K/AKT
signaling may make a major contribution to reducing the
incidence and progression of prostate cancer.
Isothiocyanates such as sulforaphane [SF; (-)-1-isothio-
cyanato-(4R)-methylsulfinylbutane] have been shown to
reduce prostate tumour growth and pulmonary metastasis
in the TRAMP mouse model of prostate cancer [3,4], and
to reduce the growth of prostate cancer xenografts in
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PC3 metastatic cell line [5]. Isothiocyanates have been
shown to exhibit several potential chemoprotective activ-
ities in cell and animal models [6,7], including the partial
suppression of pAKT expression [3,8]. The biological
activity of isothiocyanates may also provide an explanation
for the inverse correlation between diets rich in crucifer-
ous vegetables such as broccoli (the major source of SF in
the diet) and the incidence and progression of prostate
cancer found in both case control and prospective epide-
miological studies [9-12]. Moreover, in a recent human
intervention study it was shown that a diet rich in broccoli
resulted in changes in gene expression associated with
insulin and EGF signaling in prostate tissue of men who
had been diagnosed with high grade PIN (HGPIN) [13],
suggesting a potential effect of sulforaphane on PI3K/AKT
signaling in humans. Thus, dietary isothiocyanates may be
potential candidates to target cells with PTEN deletion or
inactivation and enhanced pAKT expression in pre-can-
cerous prostate tissue.
In the current study, we initially show that that there
is significant variation in PTEN and pAKT expression in
non-neoplastic tissue of men who had previously been
diagnosed with HGPIN. We then demonstrate that SF
has differential effects on the viability and proliferation
of human cell lines that differ in PTEN expression. We
additionally report with the use of PTEN
L/L;PB-Cre4
mice [14], that dietary intervention with SF has no effect
on gene expression in mouse prostate tissue with PTEN
expression, whereas in isogenic PTEN-deficient tissue
SF acts to attenuate and reverse changes in PTEN dele-
tion-mediated gene expression and induces additional
changes in gene expression. We also show that there is
a significant overlap in changes in gene expression
induced by SF in PTEN null prostate tissue of mice with
that induced in prostate tissue of men consuming a
broccoli-rich diet. Finally, through the use of exon
arrays, we find that SF interacts with PTEN deletion to
both attenuate and promote alternative gene splicing.
Our results support the finding that cells that have
PTEN deletion and associated activation of PI3K/AKT
signaling are hypersensitive to SF. It is possible that this
leads to these cells being less competitive in growth
compared to cells with wild type PTEN expression and
provides an explanation of how consuming broccoli can
reduce the risk of prostate cancer incidence and pro-
gression. In addition, it suggests potential therapeutic
applications for sulforaphane.
Results
Heterogeneity of expression of PTEN and pAKT in non-
neoplastic tissue from men diagnosed with HGPIN
W eo b t a i n e dT R U S - g u i d e dp r o s t a t eb i o p s yt i s s u ef r o m
21 volunteers who had previously received a diagnosis
of HGPIN (mean time since diagnosis 135 ± 107 days,
mean age 64 ± 4.3 years), and investigated PTEN and
pAKT expression via immunohistochemichal staining in
non-neoplastic prostate tissue. We found extensive het-
erogeneity in pAKT expression both among and within
individuals (Figures 1 and 2). We also found extensive
variation in expression of PTEN, with cells having both
nuclear and cytoplasmic expression, solely cytoplasmic
expression or neither nuclear nor cytoplasmic expres-
sion (Figures 1 and 3). While intense pAKT expression
was associated with lack of both nuclear and cytoplas-
mic PTEN expression, a close inverse association
between pAKT and PTEN expression was not apparent.
In particular, epithelial cells from atrophic glands often
had both pAKT and PTEN expression (Figure 1).
The dietary isothiocyanate sulforaphane inhibits the
growth of the cancerous PTEN-deficient PC3 prostate cells
at lower concentrations than the non-cancerous PNT1A
cell line
As an initial investigation into the potential interaction
between PTEN deletion and SF, we quantified the effect
of SF on the growth and proliferation of a human can-
cerous prostate cell line, PC3, which is deficient in
PTEN and has high constitutive expression of pAKT
[15], compared to the non-cancerous cell line PNT1A,
which expresses PTEN and a low constitutive expression
of pAKT. We found that at low concentrations, SF
enhanced the growth and proliferation of PNTIA cells,
while inhibited the growth and proliferation of PC3
cells. Both cell lines were inhibited at higher supraphy-
siological concentrations of SF (Figure 4).
SF has differential effects on gene expression in mouse
prostate tissue that varies in PTEN expression
To explore the interaction between PTEN expression
and activity of SF specifically, we used PTEN
L/L;PB-Cre4
mice. In this model, segregation of Cre within a back-
cross generation results in PTEN deficient (‘null’)a n d
wild type (WT) PTEN mice within the same litter,
enabling the specific effects of PTEN deletion to be
investigated [14]. We supplemented the diet of PTEN
null mice and their WT littermates with either 0.1 μMol
SF/g diet (low SF diet, LSF) or 1 μMol SF/g diet (high
SF diet, HSF) and compared it to mice fed a control
diet without added SF.
WT mice had normal prostate histology. However, at
eight weeks foci of mild epithelial hyperplasia were
observed in some sections, although they were not sig-
nificantly associated with diet. PTEN deletion at both
five and eight weeks was confirmed through RT-PCR
analyses of prostate tissue (data not shown) and immu-
nohistochemichal staining (Figure 5). Histopathological
development of murine prostate intraepithelial neoplasia
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Page 2 of 23(mPIN) due to PTEN deletion was very similar to that
previously described [14]. PTEN null prostate tissue
from five-week old mice exhibited epithelial hyperplasia
and some foci with early indication of mPIN which also
showed increased pAKT expression. This association
was more prominent at eight-weeks, where pAKT was
highly expressed in all epithelial cells, with most glands
exhibiting mPIN. Ki67 was widely expressed at both five
and eight weeks in PTEN null prostate tissue but
expression of phosphorylated mTOR was only detected
at eight weeks (Figure 6). Diet did not have an obvious
effect on the appearance of mPIN or expression of these
proteins.
PTEN deletion resulted in multiple changes in gene
expression at both five weeks and eight weeks (Table 1),
associated with epithelial hyperplasia and mPIN,
Figure 1 Heterogeneity in PTEN and pAKT expression in non-malignant human prostate tissue.R e p r e s e n t a t i v ee x a m p l e so fn o n -
malignant human prostate tissue illustrating heterogeneity of PTEN and pAKT expression: (A) illustrates high level of nuclear and cytoplastic
expression of PTEN with no pAKT expression, (B) illustrates loss of PTEN expression with enhanced pAKT expression, (C) illustrates loss of PTEN
expression without apparent increase in pAKT, (D) illustrates expression of both PTEN and pAKT associated with atrophy. Bar = 100 μm.
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in changes in expression of 198 transcripts (adjusted p <
0.05), while at eight weeks the deletion resulted in
changes in expression of 989 transcripts (Table 1, Addi-
tional file 1 - S1). These are designated ‘5-week and 8-
week PTEN signature genes’. 135 transcripts were com-
mon between these two lists of genes, which was signifi-
cantly greater than the 11 transcripts that would have
been expected by chance (Fishers exact test, p = 5.8 ×
10
-44). A previous study reported changes in gene
expression in the same mouse model between wild type
prostate tissue and invasivea d e n o c a r c i n o m ai nP T E N
null prostate tissue obtained 26-29 weeks after birth, in
which there were changes in expression of 1041 out of a
possible 10290 genes/ESTs that were present on a cus-
tom-made cDNA array [14]. We compared this list with
our 5-week and 8-week PTEN signature gene lists for
which we had Unigene designations (193 and 963
respectively), but found little overlap between either the
5 week PTEN signature list or the 8 week PTEN signa-
ture list with the gene list obtained from analyses of tis-
sue after 26-29 weeks (Figure 7). The five genes that
were in common in all three lists are chemokine (C-C
motif) ligand 20 (Ccl20), extracellular proteinase inhibi-
tor (Expi), G protein-coupled receptor family C group 5
member A (Gprc5a), CD24a antigen (Cd24a) and
calcium and integrin binding 1 (calmyrin, Cib1). It is
therefore likely that PTEN deletion initiates a transcrip-
tional cascade, in which genes that are altered in their
expression in the early phase are distinct from that in
the later phases associated with metastatic disease.
We found very few changes in prostate transcript
expression induced by SF in the WT mice at 5 or 8
weeks of age (Table 1). In contrast, there were many
dose-dependent changes in gene expression induced by
SF in the PTEN null background (Table 1), suggesting
that the effects of SF are dependent upon activation of
PI3K/AKT signalling pathway due to PTEN deletion.
This would explain how SF may have selective effects
towards cells that are liable to proliferate. For further
insight into the changes induced by the HSF diet, we
undertook functional analyses with GenMAPP and
found that there was a high frequency of genes specifi-
cally associated with PI3K/AKT mediated metabolic
processes, such as amino acid, fatty acid, glucose meta-
bolism and apoptosis (Table 2). When we compared the
changes in expression of the genes induced by HSF to
those that occurred in the PTEN null background com-
pared to the WT background, we found that there was
an inverse association. This indicates that the SF was
able to suppress pAKT-mediated gene expression
(Figure 8).
A comparison between gene expression modulated by SF
in mice and gene expression modulated by a broccoli-
rich diet in humans
One rationale of feeding SF to PTEN knock out mice is
that it is a model for the potential protective effects of
broccoli on the development of prostate cancer in
humans, partially validated by our observations that
PTEN deletion may occur early in human prostate carci-
nogenesis (Figure 1). We thus sought to see if there was
a significant overlap in the genes induced by SF in the
PTEN null mice with previously obtained data on the
changes in gene expression in sequential prostate biop-
sies of men who were deemed to be at risk of prostate
cancer following a 12 month dietary intervention with
either broccoli or peas, as previously described [13]. In
this study, men who had previously received a diagnosis
of HGPIN, and exhibited heterogeneity in expression of
PTEN and pAKT (Figures 1 and 2), were randomized
into two dietary intervention groups, in which they were
required to consume either 400 g of peas per week or
400 g of high glucosinolate broccoli per week for
12 months but to otherwise follow their normal diet
which was quantified through the use of diet diaries.
Global gene expression was quantified through the use
of human Affymetrix arrays in sequential biopsies
obtained before and after the intervention from each of
the volunteers, as previously described. We converted
Figure 2 Variation in pAKT expression in non-malignant tissue
of 22 men who had previously received a diagnosis of HGPIN.
The immmunohistochemical score (Q) of tissue samples was
determined by estimating the percentage of epithelial cells
positively stained for pAKT (P) and multiplying it by the intensity of
the staining (I).Weak staining was scored 1, moderate staining
scored 2, and strong staining scored 3 to give a possible maximum
score of 300 (Q = P × I). The data were divided into sextiles and the
frequency (%) of volunteers in each sextile is shown here.
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intervention into their human orthologues using the
HomoloGene database at the NCBI website. We initially
undertook comparisons between the human 156 Affy-
metrix probe sets orthologues of the 80 mouse genes
that were altered in expression by HSF after five weeks
(Table 1) with human genes that were altered in expres-
sion in prostate biopsy samples taken from volunteers
before and after a 12-month intervention with the broc-
coli-enriched diet (5859 Affymetrix probesets). We
found that 30 probesets were common to both lists,
which was significantly greater (p < 0.002) than the 16
Figure 3 Localisation of PTEN expression in non-neoplastic human prostate tissue.( A and B) Nuclear and cytoplasmic expression of PTEN,
(C and D) cytoplasmic but lack of nuclear expression of PTEN, (E and F) high level of nuclear expression of PTEN with reduced levels of
cytoplasmic expression. Bars = 100 μm( A, C and E), 30 μm( B, D and F).
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When we compared the changes in gene expression in a
similar group of men whose diet had been enriched
with peas (4947 Affymetrix probesets), we found that 22
probesets were common to both lists, which was also
significantly greater than that which we would expect by
chance (14 probesets, p = 0.023). When we combined
the three data sets (Figure 9), we found that 19 probe-
sets were common to the three data sets. When we
repeated the analysis with the 72 mouse genes that were
altered in expression after eight weeks, we found no sig-
nificant overlaps with the human data.
Interaction of PTEN deletion and SF in modulating gene
expression
We then compared gene expression profiles between
WT mice fed the control diet and PTEN null mice that
had been fed either the control diet or diets supplemen-
ted with SF to investigate the combined effects of PTEN
deletion and diet. When tissue was analysed at five
weeks of age, it was apparent that the addition of SF to
the diet had two effects. The LSF diet reduced the num-
ber of PTEN signature gene changes from 198 to 66,
while inducing changes in expression of 221 additional
g e n e st h a th a dn o tp r e v i o u s l yb e e np e r t u r b e db yt h e
PTEN deletion. These additional gene changes induced
by LSF were associated with phosphate transport, cell
adhesion and extracellular matrix organisation (Addi-
tional file 2 - Table S2). The HSF diet suppressed all
changes in gene expression that had previously been
induced by the PTEN deletion, and did not induce any
additional changes in gene expression (Table 1).
The lack of statistically significant differences in gene
expression between WT mice and PTEN null mice fed
the HSF diet appeared inconsistent with epithelial
hyperplasia observed in these mice at five weeks of age.
We therefore compared the extent of the magnitude of
changes in expression of the PTEN signature genes
induced by the PTEN deletion with the control diet to
that when the diet was supplemented with SF. We
f o u n dt h a tt h eH S Fd i e th a dn o te n t i r e l ys u p p r e s s e d
changes in the PTEN signature genes, but attenuated
the extent of the changes by about 33% (Figure 10A,
Additional file 1 - Table S1), so that none of them alone
reach statistical significance. Likewise, the LSF sup-
pressed the extent of changes in the PTEN signature
genes by 23% (Additional file 1 - Table S1). As there
was similar suppression in all the PTEN signature genes,
regardless of whether they had been up- or down-regu-
lated or their ontological association, it is likely that SF
has a direct effect on suppressing PI3K/AKT signalling.
However, in this model the extent of suppression of
PTEN null-mediated gene expression was insufficient to
suppress pathological changes in prostate tissue.
When gene expression profiles were analysed in pros-
tate tissue from eight week old mice, SF could again be
observed to have two effects. First, the LSF and HSF
diets reduced the number of PTEN signature gene
changes from 989 to 723 and 761, respectively (Figure
11). This more modest reduction was also reflected in
the similarity of changes in the magnitude of expression
of the majority of the 989 genes in PTEN null mice fed
either the control diet, or diets supplemented with LSF
or HSF (Figure 10B). However, both SF diets attenuated
Figure 4 Viability and proliferation of PNT1A and PC3 human prostate cells. A, Expression of PTEN in PNT1A and PC3 cells. B, Viability of
PNT1A and PC3 cells in response to 24 h treatment with SF relative to control measured by WST-1 assay. C, Proliferation of PNT1A and PC3 cells
in response to 24 h treatment with SF relative to control measured by ELISA following BrdU incorporation. * p ≤ 0.05 **p ≤ 0.001.
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involved in positive regulation of cell differentiation, cell
division and post-translational protein modification
(Additional file 3 - Table S3). Secondly, the addition of
SF to the diet of PTEN null mice resulted in changes in
the expression of additional genes (Figure 11, Additional
file 4 - Table S4). Pathway analyses of the genes that
were altered in expression due to the PTEN deletion
and its interaction with SF is summarised in Table 3. As
would be expected, certain pathways, associated with
changes induced by the PTEN deletion were common
to PTEN null prostate tissue regardless of diet, such as
immune and inflammatory response, whereas mice that
had diets supplemented with SF had additional changes
in pathways associated with cell cycle regulation and
apoptosis (Table 3). The change in expression of genes
within these pathways were indicative of SF inducing
cell cycle arrest and apoptosis (Additional file 5 - Table
S5; Additional file 6 - Table S6). For example, the up
regulation of cyclin B1 and the down regulation of
cyclin D2 are consistent with cell cycle arrest, and the
two fold increase in expression of caspases 3 and 7 are
Figure 5 Representative sections of mouse prostate illustrating effect of PTEN deletion on expression of PTEN and pAKT. Bar = 100 μm.
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tosis. It is notable that we did not observe significant up
regulation of Nrf2 regulated genes.
As an overview, the data on changes in gene expres-
sion suggest that SF has two effects: it can both suppress
PTEN deletion - mediated gene transcription, such as
that observed at five weeks, particularly by the HSF diet,
as well as inducing additional changes in gene expres-
sion. The balance between these two effects, and thus
the overall changes in gene expression, depends upon
the age of the mouse and the concentration of SF.
Interaction of PTEN deletion and SF on modulating
alternative splicing
The development of high density exon arrays facilitates
the global analyses of alternative splicing events. Several
statistical approaches have been developed to analyse
the large and complex data sets arising from the use of
t h e s ea r r a y s[ 1 6 ] ,o fw h i c hw eu s e dF I R M A( ’Finding
Isoforms using Robust Multichip Analysis’) [17], specifi-
cally developed for analysing Affymetrix exon array data
and implemented in the aroma.affymetrix package of R/
Bioconductor [18]. Briefly, FIRMA scores each exon as
Figure 6 Representative sections of mouse prostate illustrating effect of PTEN deletion on expression of Ki67 (arrows) and
phosphorylated mTOR (red staining). Bar = 100 μm.
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script expression level and are used to perform further
statistics to identify alternative splicing events.
Initially, we compared changes in exon FIRMA pro-
files induced by SF in WT or PTEN null genetic back-
grounds. In a similar manner to that observed for
transcriptional changes, SF induced only potential
splicing events in the PTEN null background implying
the need for activated PI3K/AKT signalling (Table 4).
However, the greatest number of exon skipping/inclu-
sion was evident when comparisons were made between
WT mice and PTEN null mice whose diets had been
supplemented with SF (Table 4, Additional file 7 - Table
S7), indicating that SF interacts with the PTEN deletion
Table 1 Changes in transcript expression in PTEN null and WT mice following SF-rich diets (LSF, HSF) and control diet
(CO)
Comparison Five weeks Eight weeks
p < 0.1
1 p < 0.05
1 p < 0.01
1 p < 0.1
1 p < 0.05
1 p < 0.01
1
WT
LSF vs CO 0 0 0 3 3 0
HSF vs CO 3 0 0 0 0 0
PTEN null
LSF vs CO 17 3 0 26 12 1
HSF vs CO 286
2 80
3 11 189 72 25
Interaction
PTEN null CO vs WT CO 385 198
4 8 1542 989
5 296
PTEN null LSF vs WT CO 660 287 42 2379 1718
5 822
PTEN null HSF vs WT CO 15 0 0 3380 2390
5 1204
1 Benjamini and Hochberg adjusted P-values between the two groups.
2 Further details of these transcripts are provided in Figure 8 and Table 2.
3Human orthologues of these transcripts were identified and compared to results from a human dietary intervention study performed previously (Figure 9).
4Details of these transcripts and their expression are provided in Figure 10A and Additional file 1 - Table S1.
5Functional analyses of these transcripts are provided in Table 3, and further analyses in Figure 11.
Figure 7 Overlap of PTEN signature genes (restricted to those with a Unigene designation) changed after 5 and 8 weeks and after 26-
29 weeks. *this study; **data from Wang et al. (2003).
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Page 9 of 23Table 2 Functional analysis using GenMAPP of genes changed in response to the high sulforaphane diet in five week
old PTEN null mice compared to the control diet
Number
Changed*
Number
Measured**
Adjusted P-
value***
Amino acid metabolism
Mm_Metabolism-of-amino-acids-and-related-nitrogen-containing-molecules_Reactome-
COREG
26 225 0.001
Mm_Valine-leucine-and-isoleucine-biosynthesis_KEGG-COREG 11 48 0.001
Mm_Glyoxylate-and-dicarboxylate-metabolism_KEGG-COREG 12 63 0.004
Mm_Glycine-serine-and-threonine-metabolism_KEGG-COREG 14 85 0.004
Mm_Catabolic-Pathways-for-Arginine-Histidine-Glutamate-Glutamine-and-
Proline_BioCarta-COREG
12 67 0.004
Mm_Acetylcholine_Synthesis-COREG 11 57 0.004
Mm_Pyruvate-metabolism_KEGG-COREG 18 152 0.008
Mm_Urea-cycle-and-metabolism-of-amino-groups_KEGG-COREG 14 104 0.010
Mm_Urea_cycle_and_metabolism_of_amino_groups_KEGG-COREG 14 115 0.015
Mm_Butanoate-metabolism_KEGG-COREG 19 200 0.019
Mm_Oxidative-decarboxylation-of-pyruvate-and-TCA-cycle_Reactome-MEGINT 13 108 0.019
Mm_Propanoate_metabolism 4 13 0.02
Mm_Arginine-and-proline-metabolism_KEGG-COREG 17 176 0.02
Mm_Catabolic-Pathways-for-Methionine-Isoleucine-Threonine-and-Valine_BioCarta-
COREG
5 22 0.026
Fatty acid metabolism
Mm_Fatty_Acid_Beta_Oxidation_3_BiGCaT-COREG 18 69 < 0.001
Mm_Fatty_Acid_Beta_Oxidation_Meta_BiGCaT-COREG 26 174 < 0.001
Mm_Fatty_Acid_Beta_Oxidation_1_BiGCaT-COREG 19 140 0.003
Mm_Fatty_Acid_Beta_Oxidation_3_BiGCaT 4 8 0.004
Mm_Fatty_Acid_Beta_Oxidation_3_BiGCaT-MEGINT 7 24 0.004
Mm_Fatty_Acid_Beta_Oxidation_Meta_BiGCaT 8 32 0.004
Mm_Unsaturated_Fatty_Acid_Beta_Oxidation_BiGCaT 3 6 0.009
Mm_Fatty_Acid_Beta_Oxidation_2_BiGCaT 3 6 0.009
Mm_Fatty_Acid_Synthesis_BiGCaT-COREG 14 103 0.009
Mm_Fatty_Acid_Beta_Oxidation_2_BiGCaT-COREG 8 38 0.009
Mm_Fatty_Acid_Beta_Oxidation_Meta_BiGCaT-MEGINT 11 82 0.020
Glucose metabolism
Mm_Glycolysis_and_Gluconeogenesis-COREG 22 204 0.008
Mm_Glutamate-metabolism_KEGG-COREG 19 165 0.008
Mm_Glycolysis-Gluconeogenesis_KEGG-COREG 20 217 0.019
Mm_Metabolism-of-glucose-other-sugars-and-ethanol_Reactome-COREG 21 248 0.020
Apoptosis
Mm_Opposing-roles-of-AIF-in-Apoptosis-and-Cell-Survival_BioCarta-COREG 12 50 < 0.001
Mm_HSP70_and_Apoptosis-COREG 12 68 0.007
Mm_Role-of-Mitochondria-in-Apoptotic-Signaling_BioCarta-COREG 12 70 0.008
Mm_Apoptosis_Reactome-COREG 12 76 0.009
Mm_Apoptotic-Signaling-in-Response-to-DNA-Damage_BioCarta-COREG 12 87 0.015
Mm_Induction-of-apoptosis-through-DR3-and-DR4-5-Death-Receptors _BioCarta-COREG 11 75 0.015
Mm_Caspase-Cascade-in-Apoptosis_BioCarta-COREG 11 95 0.059
Krebs-TCA cycle
Mm_Krebs-TCA_Cycle 11 29 < 0.001
Mm_Citrate-cycle-TCA-cycle_KEGG-COREG 26 167 < 0.001
Mm_Krebs-TCA_Cycle-COREG 30 216 < 0.001
Mm_Oxidative-decarboxylation-of-pyruvate-and-TCA-cycle_Reactome-COREG 20 124 < 0.001
Mm_Krebs-TCA_Cycle-MEGINT 17 153 0.011
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of the genes that were potentially alternatively spliced
by SF are shown in Additional file 8 (Table S8). A large
proportion of genes for which there was indication of
alternative splicing also showed perturbed overall tran-
script expression by SF (74% for HSF and 47% for LSF),
suggesting that alternative splicing by SF is coupled to
transcription.
We selected DMBT1 (Deleted in Malignant Brain
Tumors 1), a gene involved in innate immunity, cell dif-
ferentiation and tumour suppression [19], to explore
further the effects of PTEN genotype and SF on gene
Table 2 Functional analysis using GenMAPP of genes changed in response to the high sulforaphane diet in five week
old PTEN null mice compared to the control diet (Continued)
Other
Mm_Electron_Transport_Chain-COREG 42 298 < 0.001
Mm_Shuttle-for-transfer-of-acetyl-groups-from-mitochondria-to-the-cytosol_BioCarta-
COREG
18 100 < 0.001
Mm_Ceramide-Signaling-Pathway_BioCarta-COREG 13 77 0.004
Mm_Reductive-carboxylate-cycle-CO2-fixation-_KEGG-COREG 13 74 0.004
Mm_Malate-aspartate-shuttle_BioCarta-COREG 9 41 0.007
Mm_Nitrogen-metabolism_KEGG-COREG 13 81 0.008
Mm_Ribosomal_Proteins 11 63 0.008
Mm_Electron_Transport_Chain 11 66 0.009
Mm_Stress-Induction-of-HSP-Regulation_BioCarta-COREG 11 67 0.009
Mm_D4-GDI-Signaling-Pathway_BioCarta-COREG 11 71 0.011
Mm_Carbon-fixation_KEGG-COREG 19 187 0.015
Mm_Nucleotide-metabolism_Reactome-COREG 34 517 0.019
Only pathways with adjusted P-values ≤ 0.05 are shown.
*Refers to the transcripts from the input 286 transcript list (adjusted P ≤ 0.1) that are present in the specific pathway. **Refers to the total number of transcripts
that are present in the pathway.***P-values were calculated in GenMAPP using a non-parametric statistic based on 2000 permutations of the data and further
adjusted for multiple testing by Westfall-Young adjustment.
Figure 8 SF reverses changes in gene expression induced by the PTEN deletion. Comparative analyses of changes in gene expression in
five-week old PTEN null mice fed SF diet compared to PTEN null mice fed control diet, and expression of the same genes in PTEN null mice fed
control diet to WT mice fed control diet. The inverse association indicated that SF suppresses gene changes associated with PTEN deletion.
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Page 11 of 23expression and splicing. FIRMA analyses suggested sig-
nificant effects of PTEN deletion and SF on splicing of
several exons (Figure 12) that was consistent with two
known splice variants of DMBT1, the shorter isoform,
designated as DMBT1-201 which is missing exons 1, 2
and 7 and 10, and the longer isoform, DMBT1-202
which contains these exons (Figure 13A). We designed
PCR primers within exons 1, 3, 4 and 10 which would
distinguish the two isofoms (Figure 13A).
At five weeks of age, neither PTEN nor SF had an
effect on overall expression of the DMBT1 transcript
(Figure 13B). However, we found that all WT mice,
regardless of diet, lacked amplification of PCR products
due to the likely absence of exons 1 and 10, consistent
with the expression of the shorter isoform. In contrast,
all PTEN null mice fed the control diet had expression
of the longer isoform (Figure 13C(i) and (iii)). However,
five-week old PTEN null mice fed the SF diets varied in
which isoform they expressed (Figure 13C(i) and (iii)),
indicative of a possible effect of SF on suppression of
alternative splicing induced by PTEN deletion, similar to
the manner by which SF can suppress PTEN deletion-
mediated gene expression at five weeks (Figures 8 and
10A, Additional file 1 - Table S1).
After eight weeks, there was a significant effect on
expression of the DMBT1 transcript by PTEN genotype
(p > 0.001), SF (p = 0.008), and by a PTENxSF interac-
tion (p = 0.007, Figure 13B), illustrating the manner by
which PTEN and diet can interact to determine gene
expression, evident from Table 1. Eight-week old WT
mice, regardless of diet, express the short isoform
whereas PTEN null mice, again regardless of diet, all
expressed the long isoform (Figure 13C(ii) and (iv)). It is
not possible to say from these preliminary analyses
whether at eight weeks the enhanced transcription of
DMBT1 by SF induces the PTEN-mediated alternative
splicing. However, the large number of genes within
PTEN null mice on SF diets that express alternatively
spliced transcripts compared to WT mice on the control
diet (Table 4, Additional file 7 - Table S7) suggests that
this may be the case. Further studies of the interaction
between PTEN genotype and diet are required.
Discussion
Studies on the effects of dietary components, such as
isothiocyanates and fish omega-3 fatty acids, on cancer
progression have focused on reporting their effects on
tumour growth and development [20-22]. Likewise stu-
dies on gene expression associated with carcinogenesis
in animal models have frequently only centred on
changes associated with the later stages of tumour
growth and progression to metastasis [14]. In this
study we are concerned with changes in gene and pro-
tein expression that occur in the very early stages of
prostate carcinogenesis, prior to tumour development
and how they may be modulated by diet. Up to now
Figure 9 Comparison between gene changes in men on a dietary intervention and those in mice fed SF. Overlap between human genes
that are altered in expression after 12 months by a diet enriched in either peas or broccoli in men, with human orthologues of genes changed
in expression by SF in a mouse PTEN null background at five weeks. If all gene changes were independent from each other, 1.5 genes would
have been expected to be in common to all the three data sets as opposed to 19.
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Page 12 of 23preliminary results indicate that green tea catechins are
promising in suppressing cancer progression in indivi-
duals with HG-PIN but a mechanistic explanation for
this effect is not yet clear [23]. In the present study,
we sought to explore the possibility that the dietary
isothiocyanate sulforaphane has contrasting effects on
cells and tissues with differential PTEN expression.
This may provide a partial explanation of the inverse
association between diets rich in broccoli and the risk
of prostate cancer [12,24], and also suggest potential
therapeutic applications of sulforaphane and related
compounds.
Figure 10 Effect of HSF on the expression of the PTEN null signature genes. A, Expression of the five week 198 PTEN signature list in PTEN
null mice fed the control diet compared to WT mice fed control diet, and 5-week old PTEN null mice supplemented with HSF diet compared to
WT mice fed control diet. The addition of SF results in the magnitude of change in expression of each gene being suppressed by on average
33% (see Table 1 and Additional file 1 - Table S1). B, Expression of the eight week 989 PTEN signature list in PTEN null mice fed control diet
compared to WT mice fed control diet, and 8-week old PTEN null mice supplemented with HSF diet compared to WT mice fed control diet (see
Table 1).The addition of SF results in the magnitude of change in expression of each gene being suppressed by on average 18%.
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Page 13 of 23Initially, we found that in men that are at risk of
prostate cancer following a previous diagnosis of
HGPIN, there is considerable variation in PTEN and
pAKT expression that is not associated with obvious
histological abnormalities. Heterogeneity of expression
would be consistent with the characteristic emergence
of several cancer foci in the human prostate. PTEN
also varied in its localisation of expression. While
intense pAKT expression was associated with lack of
both nuclear and cytoplasmic PTEN expression, we
also observed loss of nuclear expression of PTEN with-
out activation of pAKT. While the function of cyto-
plasmic PTEN is to counteract increased levels of PIP3
by dephosphorylating to PIP2, thereby preventing acti-
vation of AKT and downstream signaling, the function
of nuclear PTEN is not as well defined but may be
independent of its phosphatase activity [25]. Nuclear
PTEN function leads to p53-mediated G(1) growth
arrest, cell death, and reduction of reactive oxygen spe-
cies production [26]. Recently, nuclear PTEN has also
been linked in controlling chromosomal integrity by
acting on chromatin to regulate expression of Rad51,
which reduces the incidence of spontaneous DNA dou-
ble-strand breaks [27].
To determine whether PTEN and subsequent pertur-
bation of the PI3K/AKT signaling pathway would play a
significant role in sulforaphane-mediated effects on
prostate carcinogenesis, we initially studied the human
prostate cancer cell line PC3, which has a PTEN dele-
tion, and found that it is more sensitive to growth inhi-
bition by SF than the PNT1A cell line that has wild type
PTEN expression. At low concentrations, SF enhanced
the growth of PNT1A, similar to that previously
reported for non-cancerous prostate primary epithelial
cells [7]. However, as PC3 and PNT1A cell lines would
have other differences in their genetic background, we
sought to investigate the biological activity of SF in the
mouse prostate-specific PTEN deletion model, where
progression to carcinogenesis parallels that of human
disease. By comparing PTEN-deficient and WT litter-
mates, which differ only in the expression of Cre recom-
binase and PTEN, we unambiguously showed that SF
has much greater activity in a PTEN-deficient back-
ground, indicating selectivity towards cells that are at
risk of carcinogenesis or tumour tissue itself. In addi-
tion, these effects are occurring at the early initiating
stages of prostate carcinogenesis before malignant trans-
formation has occurred.
Figure 11 Comparison of gene changes in PTEN null mice on different diets compared to WT mice fed the control diet. Overlap of
differentially expressed transcripts (P ≤ 0.05) of 8-week old PTEN null mice on the control diet (989 transcripts, ‘PTEN signature transcripts’, Table
1), low sulforaphane (LSF, 1718 transcripts, Table 1) and high sulforaphane (HSF, 2390 transcripts, Table 1) diet each compared to 8-week old WT
mice on the control diet. A, Functional analysis by GenMAPP of these genes (data not shown) confirmed that they are enriched for genes
involved in immune response, inflammatory response and response to wounding, two of which are common pathways between all three diets
(Table 3). B, Details of these genes are shown in Additional file 3 - Table S3. C, Functional analysis of these genes is shown in Additional file 4 -
Table S4.
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Page 14 of 23Table 3 Functional analysis using GenMAPP of eight week old PTEN null mice on different diets compared to WT mice
on control diet
MAPP Name Number
Changed*
Number
Measured**
Adjusted P-
value***
Control diet
immune response 40 160 < 0.001
inflammatory response 22 85 < 0.001
Mm_Inhibition-of-Matrix-Metalloproteinases_BioCarta-COREG 6 13 0.025
Mm_mRNA_processing_binding_Reactome-COREG 46 1309 0.022
Low SF diet
immune response 57 160 < 0.001
inflammatory response 36 85 < 0.001
Mm_Bile-acid-biosynthesis_KEGG-COREG 30 105 0.013
Mm_Carbon-fixation_KEGG-COREG 47 187 0.004
Mm_Electron_Transport_Chain-COREG 73 298 < 0.001
Mm_HSP70_and_Apoptosis-COREG 21 68 0.028
Mm_Metabolism-of-glucose-other-sugars-and-ethanol_Reactome-COREG 58 248 0.005
Mm_Monocyte-and-its-Surface-Molecules_BioCarta-MEGINT 9 19 0.028
Mm_Propanoate-metabolism_KEGG-COREG 23 77 0.027
Mm_Ribosomal_Proteins 29 63 < 0.001
response to chemical substance 26 93 0.029
response to wounding 42 152 0.001
High SF diet
immune response 63 160 < 0.001
inflammatory response 40 85 < 0.001
intracellular signaling cascade 64 229 0.024
Mm_Adipogenesis 39 122 0.026
Mm_Adipogenesis-MEGINT.mapp-.mapp-.mapp-.mapp-.mapp-.mapp- 62 208 0.004
Mm_Apoptotic-DNA-fragmentation-and-tissue-homeostasis_BioCarta-COREG 25 66 0.024
Mm_ATM-Signaling-Pathway_BioCarta-COREG 30 77 0.003
Mm_B_Cell_Receptor_NetPath_12 48 137 0.001
Mm_cdc25-and-chk1-Regulatory-Pathway-in-response-to-DNA-damage_BioCarta-
COREG
39 121 0.024
Mm_Cell_Cycle_KEGG 29 77 0.010
Mm_Cell-Cycle-Checkpoints_Reactome-COREG 54 157 < 0.001
Mm_Cyclin-E-Destruction-Pathway_BioCarta-COREG 23 53 0.003
Mm_E2F1-Destruction-Pathway_BioCarta-COREG 31 90 0.027
Mm_GPCRDB_Other 3 139 0.025
Mm_Hedgehog_Netpath_10-COREG 46 141 0.004
Mm_IL-3_NetPath_15 30 87 0.030
Mm_IL-5_NetPath_17 26 62 0.003
Mm_Influence-of-Ras-and-Rho-proteins-on-G1-to-S-Transition_BioCarta-COREG 27 72 0.018
Mm_NF-kB-Signaling-Pathway_BioCarta-MEGINT 16 34 0.018
Mm_RB-Tumor-Suppressor-Checkpoint-Signaling-in-response-to-DNA-
damage_BioCarta-COREG
40 124 0.019
Mm_Ribosomal_Proteins 25 63 0.015
Mm_Role-of-BRCA1-BRCA2-and-ATR-in-Cancer-Susceptibility_BioCarta-COREG 30 79 0.004
response to wounding 49 152 0.003
Only pathways with adjusted P-values ≤ 0.05 are shown. Pathway analysis was performed on transcript lists that were statistically significant (Benjamini and
Hochberg adjusted P ≤ 0.05,) between the two groups. No fold cutoff was used.
* Refers to the transcripts from the input transcript list identified for each diet that are present in the specific pathway. **Refers to the total number of
transcripts that are present in the pathway. ***P-values were calculated in GenMAPP using a non-parametric statistic based on 2000 permutations of the data
and further adjusted for multiple testing by Westfall-Young adjustment.
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Page 15 of 23The effects of SF on gene expression in PTEN-deficient
prostate tissue were complex. After five weeks, the main
effect is to ameliorate PTEN null-mediated gene expres-
sion, so that SF itself acted as a surrogate PTEN tumour
suppressor, although its effects were not sufficient in this
model to reverse the histopathological changes induced
by the knock out of PTEN in all prostate epithelial cells.
At a later stage, while SF continued to inhibit a subset of
PTEN null-mediated gene expression, it also changed the
expression of other genes that are associated with cell
cycle arrest and apoptosis. For example, the HSF diet up-
regulated cyclins A2, B1, B2, E1 and E2, down-regulated
cyclin D2 and induced their associated cyclin-dependent
kinases, Cdk2 and 6 (Additional file 5 - Table S5). These
results are consistent with previous studies. Cell cycle
regulation by SF has been reported in prostate and colon
cell lines in which G1 phase cell cycle arrest was asso-
ciated with protein down-regulation of cyclin D1 [28,29],
and in non-transformed T lymphocytes where SF
reduced cyclin D2 [30]. Gene expression of cyclin D2 was
also down-regulated in small intestinal polyps of Apc-
Min/+ mice after 3 days of SF treatment[31]. Increased
protein expression of cyclin B1 has been reported to be
induced by SF in human colon and breast cells [32,33].
SF also resulted in a greater than 2-fold increase in
expression of caspases 3 and 7 (Additional file 6 - Table
S6), consistent with induction of apoptosis in a caspase-
dependent manner previously observed in a variety of
cell and animal models by SF [6]. For example, SF
increased caspase-3 activity in cultured PC3 human pros-
tate cancer cells [5,34] and broccoli sprouts - a rich
source of SF - retarded tumour growth associated with
caspase-3 cleavage in TRAMP mice, an alternative model
of human prostate cancer [3].
Isothiocyanates such as SF are known activators of the
NF-E2-related factor 2 (NRF2) transcription factor-sig-
naling pathway [6], and previous studies have reported
enhanced expression of NRF2-regulated genes in small
intestine and liver of wild type mice [35,36]. Surprisingly,
we did not find any enhanced expression of NRF2-regu-
lated genes in either wild type or PTEN null prostate tis-
sue. This may be due to the exposure of prostate tissue
in our mouse model to SF being significantly lower than
that used in cell studies and other mouse studies, in
order to better reflect routine dietary exposure, combined
with the probable greater sensitivities of liver and small
i n t e s t i n ec o m p a r e dt op r o s t a t et oa n yg i v e nd o s eo fS F
due to topological exposure and first pass effects, respec-
tively. However, it is noteworthy that a previous study
also reported lack of enhanced expression of NRF2-regu-
lated genes through dietary intervention with SF in
intestinal polyps of APCMin/+ mice [31], suggesting tis-
sue specific effects. Moreover, an acute intervention with
standard broccoli and a 12-month dietary intervention
with a broccoli-rich diet did not induce NRF2-regulated
genes in gastric mucosa [37] and prostate tissue [13],
respectively, in human volunteers.
In this study, using the prostate-specific PTEN dele-
tion mouse model we have provided evidence that in a
PTEN null background, addition of SF to the diet can
ameliorate the effects of the PTEN deletion. It is, there-
fore, of considerable interest to know whether dietary
intervention in men who are at risk of prostate cancer,
partly through PTEN deletion or activation of PI3K/
AKT signaling, may have a similar effect. To test this
we compared changes in gene expression induced by SF
in PTEN-null mice with previously reported changes in
human prostate tissue following diets enriched in either
broccoli (a dietary source of SF) or peas. We unexpect-
edly found evidence that both diets may induce similar
changes, although the overlap with the broccoli diet was
of greater statistical significance. It is conceivable, then,
that in addition to SF derived from broccoli, some diet-
ary component common to both diets may be able to
Table 4 Exons that are significantly changed in PTEN null and WT mice following SF-rich diets (LSF, HSF) and control
diet (CO)
Comparison Five weeks Eight weeks
p < 0.1
1 p < 0.05
1 p < 0.01
1 p < 0.1
1 p < 0.05
1 p < 0.01
1
WT
LSF vs CO 0 0 0 0 0 0
HSF vs CO 3 0 0 0 0 0
PTEN null
LSF vs CO 18 6 1 106 31 0
HSF vs CO 318 37 2 94 24 3
Interaction
PTEN null CO vs WT CO 2 0 0 36 2
2 0
PTEN null LSF vs WT CO 51 16 1 602 287
2 28
PTEN null HSF vs WT CO 4 1 1 872 267
2 35
1 Benjamini and Hochberg adjusted P-values between the two groups.
2 Details of these exons are provided in Additional file 7 - Table S7.
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Page 16 of 23suppress the downstream effects of PTEN deletion. Pos-
sible factors may be lignans, such as secoisolariciresinol,
and flavonoids which are present in both peas and broc-
coli, and which have been associated with reduction in
prostate cancer risk [38,39]. Lignans are converted by
intestinal microflora to enterodiol and enterolactone,
which have been shown to suppress pAKT expression in
cell models [40] and certain flavonoids have been shown
to modulate PI3K/AKT signalling [41].
The development of exon arrays has facilitated global
analysis of alternative gene splicing, and enables more
precise interpretation of microarray data. Alternative
splicing of primary RNA transcripts may have a variety
of functions, including the expression of different pro-
tein isoforms with different functional properties and
the regulation of gene expression through nonsense-
mediated decay [42]. Serine-rich (SR) proteins function
as important regulators of alternative mRNA splicing;
kinases and protein phosphatase 1 control the reversible
phosphorylation status of these proteins that determines
splice site selection and cellular location [43,44]. pAKT
has been shown to phosphorylate the SR proteins
SRp40, SF2/ASF and 9G8, which determine alternative
spicing of PKC and fibronectin mRNA [45,46]. Further-
more, insulin has been shown to induce the alternative
splicing of PKC via PI3K/AKT activation [47]. Thus, it
may be expected that hyperactivation of PI3K/AKT sig-
naling through PTEN deletion may lead to alternative
splicing of genes, which may have important biological
consequences. While exon arrays have been used to
compare tissue- and tumour-specific splicing in human
tissues [48,49], we are unaware of any reported analyses
that have specifically focussed on PTEN deletions or
assessed the role of diet in inducing alternative splicing.
Figure 12 Exon array analyses of alternative splicing of Dmbt1 gene with FIRMA. A, FIRMA scores calculated from array data for all the
mice are plotted in the top graphic. Each line represents values from a single mouse. Highlighted in colour are 8-week old mice [black, WT on
control diet; green, PTEN null on control diet; blue, PTEN null on LSF diet; red, PTEN null on HSF diet]. B, The normalised logged intensities of
each probeset are plotted (note that certain exons are represented by more than one probeset). The blue connecting lines map these probesets
to (C) gene models as defined by Affymetrix (green) and Ensembl (orange). Transcript isoforms known for this gene are plotted in dark blue. The
longer isoform is designated in Ensembl as Dmbt1-202 and the shorter as Dmbt1-201 (see Figure 13). The five regions highlighted in the plot
show exons with statistically significant difference in FIRMA scores between 8-week PTEN null mice on HSF diet and WT mice on control diet.
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PTEN deletion and supplementation of diet with SF can
result in the alternative splicing of many genes. This is
likely to be a complex interaction of both PTEN dele-
tion and SF affecting phosphatase activity, as has been
shown for other isothiocyanates [50] and overall changes
in gene transcription induced by SF. Indeed, the HSF
diet altered expression of two regulatory subunits of
protein phosphatase 1 that may partly explain the
observed effects. An example of perturbed alternative
splicing is the DMBT1 gene where PTEN deletion pro-
moted the expression of the longer isoform and SF
Figure 13 RT-PCR analyses of alternative splicing of Dmbt1. There are two known transcript isoforms for this gene: the short isoform
designated in Ensembl as Dmbt1-201 and the long isoform Dmbt1-202, which has four additional exons (shown with the black arrows). A, Two
sets of primers were designed on either side of exons 2 and 7 that were shown to be alternatively spliced in response to the high SF diet.
Primer location and expected products are shown. Both sets of primers were designed to give a defined product from the long Dmbt1 isoform
but no product from the short isoform. B, Gene expression of Dmbt1. After eight weeks, there was a significant effect on expression of the
DMBT1 transcript by PTEN genotype (p > 0.001), SF (p = 0.008), and by a PTENxSF interaction (p = 0.007). C, Amplified products from five-week
old (i, iii) and eight-week old (ii, iv) mice show the effect of diet on the Dmbt1 loci flanking exon 2 (i, ii) and exon 7 (iii, iv). Note that during
amplification of the locus flanking exon 7 there is a high MW product that corresponds to the presence of genomic DNA. However, the 493 bp
mRNA product corresponding to the long Dmbt1 isoform is preferentially amplified.
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Page 18 of 23affected this process. The human DMBT1 gene, involved
in terminal differentiation of epithelial cells, is located
on chromosome 10 q, a region often deleted in prostate
cancer and also containing the PTEN tumour suppres-
sor [51]. It is also important to note that in a previous
study bioinformatic analyses of the changes in gene
expression in men with a broccoli-rich diet reported
changes in mRNA processing, indicative of alternative
splicing [13]. However, as this previous study did not
use exon arrays, it is not yet possible to quantify the
effects of diet on splicing in human prostate tissue.
Conclusion
Suppression of PI3K/AKT signaling has become a
major potential target of therapeutic or dietary inter-
vention to prevent the progression of prostate cancer,
and cancer at other sites [52]. Tumours with PTEN
loss and enhanced PI3K/AKT activity have been shown
to be less susceptible to calorific restriction than other
tumours [53], but are restricted in growth through a
diet rich in omega-3 polyunsaturated fatty acids [20].
In our current study, we focus on the manner by
which SF perturbs gene expression in non-malignant
PTEN null tissue, as opposed to later stages of
tumourigenesis and metastasis. Further studies are
required to assess the effect of SF on PTEN null-
mediated prostate tumourigenesis, although probably
with a less aggressive model more akin to the temporal
development of human prostate cancer [54,55]. Here,
we clearly demonstrate that SF interacts with PTEN-
deficient cells and tissues to modulate gene expression
and alternative splicing events. This may explain how
diets rich in broccoli, the dietary source of SF, can
reduce the risk of incidence of prostate cancer and the
progression of localised prostate cancer to more
aggressive forms of this disease [12]. Furthermore, it
emphasises the complexities of the interaction between
genotype, gene expression and diet.
Materials and methods
Ethics statement
This study was conducted according to the principles
expressed in the Declaration of Helsinki. The study was
approved by the East Norfolk & Waveney Research
Governance Committee and the Norfolk Research Ethics
Committee (references 05/Q0101/9 and 09/H0311/96).
All patients provided written informed consent for the
collection of samples and subsequent analyses.
All animals were handled in strict accordance with
good animal practice and all animal work was
approved by the University of East Anglia Animal
Ethics Committees and covered by the appropriate
licences under the UK Home Office Animal Proce-
dures Act, 1986 (PPL 80/1799).
Human subjects
Trans-Rectal Ultra Sound (TRUS)-guided needle biopsy
tissues were obtained from men who had previously
received a diagnosis of high grade prostatic intraepithe-
lial neoplasia (HGPIN) via the Urology Clinic at the
Norfolk and Norwich University Hospital as previously
described [13]. Briefly, RNA was extracted from whole
biopsy tissues for gene expression analysis and adjacent
biopsies were evaluated by histology. Although the latter
did not contain neoplastic cells, we cannot exclude the
presence of these cells in the biopsies used for gene
expression analysis. Details of the volunteers (age, BMI,
PSA, GSTM1 genotype) are as previously described [13].
Cell culture and proliferation assays
The human post-pubertal prostate normal (PNT1A) cell
line and the human Caucasian prostate adenocarcinoma
(PC3) cell line were obtained from the European Collec-
tion of Cell Cultures (ECACC). PNT1A and PC3 cells
were routinely cultured as monolayers in RPMI-1640
and HAMS media, respectively, supplemented with 10%
fetal bovine serum (FBS) in a humidified atmosphere
containing 5% CO2 at 37°C. Cells were grown to 70-80%
confluence before incubation in complete media with
various concentrations of SF. Cell viability was deter-
mined following a 24 h treatment with either SF or
v e h i c l eD M S Ou s i n gt h eW S T - 1C e l lP r o l i f e r a t i o n
Reagent (Roche Applied Science). Cell proliferation was
assessed by ELISA following BrdU incorporation (Roche
Applied Science).
Animal Husbandry and Genotyping
PTEN
L/L;C
+ mice were generated by crossing ARR2Pro-
basin-Cre transgenic mice, PB-Cre4 [56], to PTEN
L/L
mice [57] as described before [14]. Only F2 generation
male offspring (PTEN
L/L;C
+ ) and their littermate con-
trols (PTEN
L/L;C
-) were used in this study. For simpli-
city PTEN
L/L;C
+ mice will be referred to as PTEN null
and PTEN
L/L;C
- mice as wild type (WT). PB-Cre4 mice
(strain B6.D2-Tg(Pbsn-cre)4Prb) were obtained from the
Mouse Models of Human Cancers Consortium
(MMHCC) of the National Cancer Institute, US, and
PTEN
L/L mice (strain C;129S4-PTEN
tm1Hwu/J) from the
Jackson Laboratories (http://jaxmice.jax.org). Mice were
housed in a room with controlled humidity, temperature
and light within the Disease Modelling Unit at the Uni-
versity of East Anglia.
Genotyping for the Cre recombinase and PTEN genes
was performed by PCR using tail tip DNA. DNA was
extracted using the QIAGEN DNA blood and tissue kit
(QIAGEN). For the PB-Cre4 genotyping we used two
sets of primers, one specific to the transgene producing
a 199 bp product (5′-ACC AGC CAG CTA TCA ACT
CG-3′ and 5′-TTA CAT TGG TCC AGC CAC C-3′)
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product (5′-CTA GGC CAC AGA ATT GAA AGA
TCT-3′ and 5′-GTA GGT GGA AAT TCT AGC ATC
ATC C-3′). Excision of exon 5 of the PTEN gene was
determined by the size of the product from the PCR
amplification using the primers 5′-ACT CAA GGC
AGG GAT GAG C-3′ and 5′- GCC CCG ATG CAA
TAA ATA TG-3′, where 1.2 Kb results from a wild-type
PTEN allele and 1.3 kb from a mutant allele.
Diet formulations and experimental design
Animal feed consisted of basal diet (AIN-93G, control
diet) or basal diet enriched with either 0.1 μMol SF/g
diet (LSF diet) or 1 μMol SF/g diet (HSF diet). D, L-SF
was purchased from LKT laboratories (St. Paul, MN,
USA) and was incorporated into the basal diet by Har-
lan Teklad (Madison, WI, USA). SF levels were con-
firmed in the diets by LC-MS as described previously
[58]. It is noteworthy that that we chose lower SF levels
compared to previous studies, ranging between 1.2-3.4
μMol SF/g [4,21], so that the intake would reflect more
physiological dietary exposure. Homozygous male PTEN
null mice and their littermate controls were randomly
assigned to the experimental and control diets, which
they received from weaning ad libitum for a duration of
either two weeks or five weeks. Animals were sacrificed
by CO2 asphyxiation and cervical dislocation at five and
eight weeks of age. At the time of sacrifice, the total
mouse weight was recorded. Mouse prostates were
removed immediately and either placed in RNAlater®
a n ds t o r e da t- 2 0 ° Cf o rs u b s e q uent expression analysis
(n = 3 per group) or fixed in 10% formalin, embedded
in paraffin wax, and used for histopathological evalua-
tions and immunohistochemichal (IHC) staining (n = 3-
5 per group).
Histopathology and immunohistochemistry
Dissected tissue samples from mouse and biopsy sam-
ples from human volunteers were fixed in 10% formal-
saline, embedded in paraffin wax and sections approxi-
mately 4 μm thick were cut. One slide from each tissue
sample was stained with hematoxylin and eosin (H&E).
For immunohistochemical assessment of both the
mouse and the human tissue samples, the slides were
deparaffinised in three changes of xylene and rehydrated
through graded ethanols (100% to 50%). Heat-induced
antigen retrieval was performed using citrate buffer pH
6.0 (Dako UK Ltd., Ely, Cambridgeshire, UK). Endogen-
ous peroxidises were quenched using 3% hydrogen per-
oxide in PBS or TBS and then blocked with 1%BSA in
PBST or 5% normal goat serum in TBST appropriate to
manufacturer’s instructions for each primary antibody.
Primary antibodies were diluted in appropriate buffer
according to the supplier’s instructions: Anti-mouse
Ki67 rat monoclonal (Dako, #M7249) diluted 1:50 in
PBST; Anti-PTEN(D4.3) rabbit monoclonal diluted
1:125 in SignalStain® Antibody Diluent(Cell Signaling,
New England Biolabs, Hitchin, UK); Anti-pAKT
(Ser473) (D9E) rabbit monoclonal diluted 1:50 in Signal-
Stain®; Anti-Phospho-mTOR (Ser2448)(49F9) rabbit
monoclonal diluted 1:50 in TBST; (Cell Signaling anti-
bodies: #9188; #4060 and #2976 respectively). All were
incubated at 37°C for 30 mins. Detection was performed
using the appropriate secondary antibody with Vector
ABC Elite kits and DAB substrate kit (Vector Labora-
tories, Peterborough, UK).
All slides were counterstained with Mayer’s haematox-
ylin (Surgipath Europe Ltd, Peterborough, UK), dehy-
drated through graded ethanols (50% to 100%), and
mounted with cover slips. Slides were visualised using
an Olympus BX60 (Olympus, Japan) microscope with
ProgRes® Capture Pro 2.1 software (Jenoptik, Germany).
Histopathological assessment was performed according
to the classification of the Bar Harbor Meeting of the
Mouse Models of Human Cancer Consortium Prostate
Pathology Committee [59]. Stained sections were evalu-
ated by two independent researchers. The immunohisto-
chemical quickscore (Q) was determined for each by
multiplying the estimated percentage of positively
stained cells (P) by the intensity of staining (I). Estimates
of intensity were scored as follows: 1 for weak staining;
2 for moderate staining and 3 for strong staining (Q = P
× I; maximum 300).
Gene expression analysis
RNA from mouse prostate tissue stored in RNAlater®
was isolated using RNeasy Mini kit (QIAGEN) and gene
expression profiling was performed using the Affymetrix
GeneChip® Mouse Exon 1.0 ST Array (Affymetrix, Santa
Clara, CA) at the Nottingham Arabidopsis Stock Centre
(Nottingham, UK) according to the Affymetrix proto-
cols. This array is a whole-genome array, containing 1.2
million probesets of four Perfect Match (PM) probes
each. A total of 36 arrays were hybridised (3 mice X 2
genotypes (WT and PTENnull) X 3 diets X 2 time-
points). Data were analysed using R/Bioconductor [60]
and the aroma.affymetrix package [18]. Linear probe
level models were fit to RMA-background corrected and
quantile normalised data to get gene- or exon-level
summaries. For annotation we used the current custom
CDF file available at the aroma.affymetrix website con-
taining the core probesets (17,831 transcript clusters;
224,053 probesets). One array was identified as an out-
lier and was removed from further analysis. Subsequent
statistical data analysis to identify differentially expressed
genes was performed using limma [61], and evaluation
of alternative splicing using FIRMA [17] packages.
Genes were identified as differentially expressed at
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Alternative splicing events were identified if the differ-
ence between FIRMA scores of two groups was statisti-
cally significant after Benjamini and Hochberg
adjustment. For the plotting of probeset-level data for
FIRMA analyses of exon array data we used the Biocon-
ductor GenomeGraphs package [62]. To identify path-
ways that were the most over-presented in the lists of
differentially expressed or alternative spliced genes,
functional analyses using MAPPFinder and GenMAPP
v2.1 were performed http://www.genmapp.org/[63]. The
Database for Annotation, Visualization and Integrated
Discovery v6 (DAVID; http://david.abcc.ncifcrf.gov/)
[64] was used to identify Gene Ontology (GO) cate-
gories associated with specific gene lists (Additional file
2 - Table S2; Additional file 3 - Table S3). Microarray
data generated in this study are compliant to MIAME
criteria and are publicly available through ArrayExpress
(Accession E-MEXP-2469).
PCR of the DMBT1 gene
Total RNA from all the mice was reverse transcribed
into cDNA using random primer synthesis from the
High-Capacity cDNA Reverse Transcription kit accord-
ing to the manufacturer’s instructions (Applied Biosys-
tems, UK). Primer pairs for the locus flanking exon 2
were 5′- TTGTGGGGTCAAATTCTGTCT-3′ and 5′-
CTCCAGCATCTTCCTGGTGT-3′ and for the locus
flanking exon 7 were 5′-CTCAAACAAGCAGTCC-
CACA-3′ and 5′-GTCCCTCCTGGATTCCACC-3′.P C R
reactions were carried out in a total volume of 50 μl
consisting of 1× green GoTaq® Flexi PCR Buffer, 0.2
mM dNTPs, 0.2 μM primer, 1 mM MgCl2, 0.025 units
of GoTaq® Flexi DNA Polymerase (Promega, UK).
Cycling conditions consisted of 2 min at 95°C for initial
denaturation, 30 cycles of denaturation for 30 sec at 95°
C, annealing for 1 min at 60°C for exon 2 and 59°C for
exon 7, and extension for 1 min at 72°C, followed by 5
min final extension at 72°C. Amplified products were
separated in 2% (w/v) agarose gels using 1 μgo ft h e5 0
bp DNA ladder (Invitrogen, UK) as a size marker and
visualised under UV following ethidium bromide
staining.
Statistical analysis of human orthologues
To estimate whether the overlap between human ortho-
logues of mouse genes induced by SF and human genes
induced by a dietary intervention was significant, we
initially assumed that the total number of probes from
the human Affymetrix U133 Plus 2.0 array and equiva-
lent probes from the mouse Affymetrix Exon 1.0 ST
array would be similar. We then performed a Monte
Carlo simulation to assess the number of expected pos-
sible probes that both change significantly in the mouse
(measured probability = 0.000467) and the human (mea-
sured probability = 0.10716). This expected number was
compared to the measured number using a Binomial
test in R [65].
Additional material
Additional file 1: Supplementary Table S1. Expression of the five-week
‘PTEN signature gene’ list comprising of 198 genes in all three diets.
Additional file 2: Supplementary Table S2. Gene ontology categories
associated with the 221 genes that were uniquely changed in five week
old mice by the LSF diet in the PTEN null compared to WT mice on
control diet.
Additional file 3: Supplementary Table S3. Gene ontology categories
associated with the 164 genes in eight-week-old mice as a result of the
PTEN deletion.
Additional file 4: Supplementary Table S4. Functional analysis using
GenMAPP of the 1997 transcripts induced by SF in addition to the PTEN
signature genes in eight week old mice.
Additional file 5: Supplementary Table S5. Expression of cell cycle-
related genes from the GenMAPP annotation that change in eight week
old PTEN null mice on high SF diet.
Additional file 6: Supplementary Table S6. Expression of apoptosis-
related genes from the GenMAPP annotation that change in eight week
old PTEN null mice on high SF diet.
Additional file 7: Supplementary Table S7. Significant FIRMA scores in
eight week old PTEN null mice fed SF diets compared to their WT
littermates on control diet.
Additional file 8: Supplementary Table S8. Functional analysis of
exons alternatively spliced between eight week old PTEN null mice on
low or high SF diets and WT mice on control diet.
Abbreviations
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sulforaphane; mPIN: murine prostatic intraepithelial neoplasia; SF:
sulforaphane.
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